» Articles » PMID: 32848374

Polymorphisms Are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2020 Aug 28
PMID 32848374
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene () and MAFLD.

Methods: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55-75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39-75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated.

Results: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones ( < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095-1.671]; =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108-1.691]; =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109-1.695]; =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103-1.759]; =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108-1.691]; =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103-1.756]; =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108-1.691]; =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103-1.756]; =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r >0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005).

Conclusion: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population.

Citing Articles

Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay.

Arvanitakis K, Chatzikalil E, Kalopitas G, Patoulias D, Popovic D, Metallidis S J Clin Med. 2024; 13(14).

PMID: 39064282 PMC: 11278502. DOI: 10.3390/jcm13144243.


Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study.

Li J, Wu N, Yang Y, Zhai X, Yuan F, Zhang F BMC Endocr Disord. 2023; 23(1):11.

PMID: 36627697 PMC: 9830772. DOI: 10.1186/s12902-022-01234-w.


Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.

Duan S, Yang D, Xia H, Ren Z, Chen J, Yao S Front Endocrinol (Lausanne). 2022; 13:1004855.

PMID: 36187093 PMC: 9523727. DOI: 10.3389/fendo.2022.1004855.


Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus-From Prevalence to Diagnostic Approach and Treatment Strategies.

Diaconu C, Guja C J Clin Med. 2022; 11(17).

PMID: 36079070 PMC: 9456683. DOI: 10.3390/jcm11175144.


Comprehensive mutations analyses of (fat mass and obesity-associated gene) and their effects on FTO's substrate binding implicated in obesity.

Kumar R, Ningombam S, Kumar R, Goel H, Gogia A, Khurana S Front Nutr. 2022; 9:852944.

PMID: 35923209 PMC: 9339907. DOI: 10.3389/fnut.2022.852944.


References
1.
Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41(4):1149-60. DOI: 10.3758/BRM.41.4.1149. View

2.
Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

3.
Fan J, Kim S, Wong V . New trends on obesity and NAFLD in Asia. J Hepatol. 2017; 67(4):862-873. DOI: 10.1016/j.jhep.2017.06.003. View

4.
Pineda-Tenor D, Berenguer J, Jimenez-Sousa M, Garcia-Alvarez M, Aldamiz-Echevarria T, Carrero A . FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients. BMC Med. 2014; 12:198. PMC: 4224698. DOI: 10.1186/s12916-014-0198-y. View

5.
Wardle J, Carnell S, Haworth C, Farooqi I, ORahilly S, Plomin R . Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008; 93(9):3640-3. DOI: 10.1210/jc.2008-0472. View